MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 78 filers reported holding MERSANA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $79,790 | -97.9% | 62,827 | -94.5% | 0.00% | -100.0% |
Q2 2023 | $3,743,174 | -20.6% | 1,137,743 | -0.9% | 0.00% | -33.3% |
Q1 2023 | $4,716,446 | -28.8% | 1,147,554 | +1.5% | 0.00% | -25.0% |
Q4 2022 | $6,625,925 | -12.4% | 1,130,704 | +1.1% | 0.00% | -20.0% |
Q3 2022 | $7,564,000 | +45.6% | 1,118,862 | -0.5% | 0.01% | +66.7% |
Q2 2022 | $5,196,000 | +12.7% | 1,124,715 | -2.7% | 0.00% | +50.0% |
Q1 2022 | $4,612,000 | +862.8% | 1,155,677 | +1400.6% | 0.00% | – |
Q4 2021 | $479,000 | -51.2% | 77,012 | -26.1% | 0.00% | – |
Q3 2021 | $982,000 | -63.2% | 104,207 | -46.9% | 0.00% | -100.0% |
Q2 2021 | $2,666,000 | -24.9% | 196,326 | -10.5% | 0.00% | -50.0% |
Q1 2021 | $3,549,000 | -41.2% | 219,398 | -3.2% | 0.00% | -50.0% |
Q4 2020 | $6,033,000 | -62.5% | 226,679 | -73.8% | 0.00% | -63.6% |
Q3 2020 | $16,109,000 | +1080.1% | 865,127 | +1383.3% | 0.01% | +1000.0% |
Q2 2020 | $1,365,000 | +2000.0% | 58,326 | +421.4% | 0.00% | – |
Q1 2020 | $65,000 | -4.4% | 11,186 | -6.1% | 0.00% | – |
Q4 2019 | $68,000 | -20.9% | 11,912 | -78.4% | 0.00% | – |
Q3 2019 | $86,000 | -69.8% | 55,054 | -21.9% | 0.00% | – |
Q2 2019 | $285,000 | -69.6% | 70,504 | -60.5% | 0.00% | -100.0% |
Q1 2019 | $938,000 | +1300.0% | 178,568 | +971.8% | 0.00% | – |
Q4 2018 | $67,000 | -88.2% | 16,660 | -70.7% | 0.00% | – |
Q3 2018 | $568,000 | -41.9% | 56,953 | +3.9% | 0.00% | – |
Q2 2018 | $978,000 | +263.6% | 54,833 | +220.0% | 0.00% | – |
Q1 2018 | $269,000 | +43.9% | 17,137 | +50.3% | 0.00% | – |
Q4 2017 | $187,000 | +29.9% | 11,405 | +35.0% | 0.00% | – |
Q3 2017 | $144,000 | +171.7% | 8,447 | +122.3% | 0.00% | – |
Q2 2017 | $53,000 | – | 3,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |